NCT05062317View on ClinicalTrials.gov

ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 26, 2022

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Liver Metastases
Interventions
DRUG

Leucovorin

Given by PO

DRUG

5-FLUOROURACIL

Given by IV

DRUG

Oxaliplatin

Given by PO

DRUG

Irinotecan

Given by IV

DRUG

Capecitabine

Given by IV

DRUG

Bevacizumab

Given by IV

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER